跳至主要内容
临床试验/NCT06700876
NCT06700876招募中不适用

Evaluation of Interferon-gamma Release Assays, Symptom Screening and Chest Radiograph for Detection of Subclinical Tuberculosis of End-stage Kidney Disease and Kidney Transplant Recipients in Thailand

Mahidol University1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2024年8月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
160
试验地点
1
主要终点
1.The number of participants with positive IGRAs among end-stage kidney disease and kidney transplant patients

研究概览

简要总结

This is an observational study among approximately 160 end-stage renal disease patients on renal replacement therapy and post-living donor or deceased donor kidney transplant recipients. Investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB/RIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.

详细描述

Patients with chronic kidney disease and end-stage kidney disease (ESKD) are at risk of developing tuberculosis and are often delayed in diagnosis. Herein, investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB/RIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • End-stage renal disease on renal replacement therapy (hemodialysis or peritoneal dialysis) or status-post-living donor or deceased donor kidney transplantation
  • Aged more than or equal 18 years

排除标准

  • Positive PPD test or a previously documented positive PPD
  • Active pulmonary or extrapulmonary tuberculosis

结局指标

主要结局

1.The number of participants with positive IGRAs among end-stage kidney disease and kidney transplant patients

时间窗: A prospective cohort study with following up period 2 years

The number of participants with positive IGRAs among end-stage kidney disease patients and kidney transplant patients

2. The number of participants with latent TB and active TB among end-stage kidney disease and kidney transplant patients during the 2-year follow-up defined by:

时间窗: A prospective cohort study with following up period 2 years

1. Latent TB: a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens (positive IGRA) with no evidence of clinically manifest active TB 2. Active TB: a disease in someone infected with Mycobacterium tuberculosis. It is characterized by signs or symptoms of active disease, or both, and is distinct from latent TB infection, which occurs without signs or symptoms of active disease

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Punnee Pitisuttithum

Professor

Mahidol University

研究点 (1)

Loading locations...

相似试验